德源药业
(832735)
| 流通市值：13.65亿 | | | 总市值：21.25亿 |
| 流通股本：5025.62万 | | | 总股本：7824.50万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 525,486,551.59 | 453,682,036.54 | 194,046,159.11 | 200,963,745.11 |
| 应收票据及应收账款 | 214,473,979.15 | 185,894,696.31 | 177,116,268.53 | 180,451,883.24 |
| 其中：应收票据 | 53,655,026.35 | 43,711,808.92 | 42,215,981.25 | 45,387,725.31 |
| 应收账款 | 160,818,952.8 | 142,182,887.39 | 134,900,287.28 | 135,064,157.93 |
| 预付款项 | 2,598,605.48 | 2,895,932.86 | 598,160.79 | 462,786.75 |
| 其他应收款合计 | 307,982.32 | 222,834.4 | 438,098.11 | 362,915.34 |
| 存货 | 57,275,186.02 | 62,470,200.99 | 65,522,304.86 | 64,059,962.28 |
| 其他流动资产 | 323,037.9 | 3,822,111.16 | 260,540.32 | 94,236.8 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 800,465,342.46 | 785,387,461.84 | 738,005,918.56 | 733,731,416.22 |
| 非流动资产: | | | | |
| 长期股权投资 | 9,461,462 | 9,433,595.85 | 9,229,961.81 | 9,280,519.91 |
| 其他权益工具投资 | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 |
| 固定资产 | 137,370,814.11 | 142,840,564.1 | 142,563,992.47 | 145,317,486.85 |
| 在建工程 | 165,048,160.73 | 155,411,974.01 | 136,388,628.1 | 100,274,299.55 |
| 使用权资产 | 236,541.26 | 413,947.16 | 546,701.26 | 894,528.12 |
| 无形资产 | 51,191,317.49 | 49,541,795.03 | 49,875,605.9 | 50,209,416.77 |
| 长期待摊费用 | 298,506.45 | 330,155.96 | 365,402.9 | 45,842.18 |
| 递延所得税资产 | 6,785,417.48 | 6,542,621.09 | 3,314,893.78 | 4,455,100.55 |
| 其他非流动资产 | 474,668.29 | 254,363.56 | 846,682.35 | 1,023,524.6 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 374,866,887.81 | 368,769,016.76 | 347,131,868.57 | 315,500,718.53 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,175,332,230.27 | 1,154,156,478.6 | 1,085,137,787.13 | 1,049,232,134.75 |
| 流动负债: | | | | |
| 短期借款 | 26,523,886.8 | 26,523,886.8 | 26,521,715.27 | - |
| 应付票据及应付账款 | 78,089,736.45 | 102,460,653.5 | 88,651,521.25 | 88,897,297.28 |
| 其中：应付票据 | 28,880,771.66 | 26,408,376.83 | 13,921,324.03 | 19,696,927.88 |
| 应付账款 | 49,208,964.79 | 76,052,276.67 | 74,730,197.22 | 69,200,369.4 |
| 合同负债 | 2,636,939.05 | 1,753,702.39 | 1,143,161.41 | 2,445,303.45 |
| 应付职工薪酬 | 13,936,921.3 | 14,686,672.86 | 23,311,673.12 | 19,256,963.43 |
| 应交税费 | 13,933,603.8 | 6,732,241.2 | 12,758,951.58 | 17,802,871.85 |
| 其他应付款合计 | 22,880,870.96 | 20,571,542.1 | 20,345,665.92 | 20,742,879.99 |
| 一年内到期的非流动负债 | 8,349,165 | 8,349,165 | 8,606,715 | 8,875,528.83 |
| 其他流动负债 | 342,802.08 | 227,981.33 | 148,610.98 | 317,889.45 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 166,693,925.44 | 181,305,845.18 | 181,488,014.53 | 158,338,734.28 |
| 非流动负债: | | | | |
| 递延收益 | 24,151,089.92 | 24,500,996.03 | 11,274,419.92 | 11,489,050.54 |
| 其他非流动负债 | - | - | - | 8,406,735 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 24,151,089.92 | 24,500,996.03 | 11,274,419.92 | 19,895,785.54 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 190,845,015.36 | 205,806,841.21 | 192,762,434.45 | 178,234,519.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 78,245,040 | 78,245,040 | 78,275,640 | 78,275,640 |
| 资本公积 | 401,896,786.82 | 401,213,389.82 | 398,952,270.21 | 398,398,419.58 |
| 减:库存股 | 8,349,165 | 8,349,165 | 8,610,705 | 16,814,460 |
| 盈余公积 | 42,279,526.38 | 42,279,526.38 | 42,279,526.38 | 42,279,526.38 |
| 未分配利润 | 470,415,026.71 | 434,960,846.19 | 381,478,621.09 | 368,858,488.97 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 984,487,214.91 | 948,349,637.39 | 892,375,352.68 | 870,997,614.93 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 984,487,214.91 | 948,349,637.39 | 892,375,352.68 | 870,997,614.93 |
| 负债和股东权益合计 | 1,175,332,230.27 | 1,154,156,478.6 | 1,085,137,787.13 | 1,049,232,134.75 |
| 公告日期 | 2024-04-24 | 2024-03-29 | 2023-10-23 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |